RIBER : Purchase order for a third Compact 21 DZ research system

Purchase order for a third Compact 21 DZ research system

Bezons, July 15^th 2014 - 5:45 pm - RIBER, the global leader for molecular beam epitaxy (MBE), is announcing the sale of a Compact 21 DZ research system.

After two machines sold during the first half of 2014, this new purchase order confirms the commercial success of the new Compact 21 DZ system since its launch onto the market at the end of 2013.

The machine will enable a leading European laboratory to increase its development capabilities for designing III-V semiconductor devices.

The Compact 21 DZ system is specifically designed for fundamental research on new compound semiconductors, particularly for structures based on III-V, II-VI, GaN materials, graphene, oxides, etc. It is well suited for the development of emerging technologies, such as UV LEDs or high-performance solar cells. Compact and flexible, it is designed to meet the needs of users looking to minimize their fixed costs.

About RIBER :
Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-tech equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to OLED flat screens and new generation solar cells.
The Riber Group recorded €23.5 million in revenues for 2013, with 109 employees at the end of 2013. The company is ISO9001 certified. Riber is listed on NYSE-Euronext Paris, Compartment "C", and is part of the CAC Small, CAC Mid & Small, CAC Technology and CAC T. HARD. & EQ indices. Riber is one of the best-rated companies in the Gaïa-index, the leading SRI index for French mid-caps. Riber is eligible for SME share-based savings schemes.

ISIN: FR0000075954 - RIB
Reuters: RIBE.PA
Bloomberg: RIB: FP
BPI France-approved innovative company

www.riber.com